Circle K triple antibiotic ointment recalled over manufacturing practice deviations
Circle K Triple Antibiotic Ointment, 0.5 oz tubes, is being recalled because of CGMP deviations observed during an FDA inspection. 2,420 tubes are affected.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall arising from inspection-observed manufacturing deviations with no product defect or consequence described, which fits the Moderate band.
Plain-English summary
Circle K Triple Antibiotic Ointment, containing bacitracin zinc 400 units, neomycin sulfate 3.5 mg and polymyxin-B sulfate 5,000 units, net weight 0.5 oz (14.2 g) tubes, manufactured for Lil' Drug Store Products, Inc., is being recalled. The action covers 2,420 tubes.
The stated reason is CGMP deviations and deficiencies observed during an FDA inspection. The FDA classified the action as Class II. The source does not describe a resulting clinical consequence.
Affected lots are 0001 and 0005, within expiry. Distribution was USA nationwide.
Consumers who have an affected lot should stop using it and follow the instructions issued by the firm.
The recalled product
- Product
- Circle K, triple antibiotic ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g) tubes, Product manufactured for Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404, Made in India, UPC…
- Manufacturer
- Dabur India Limited
- Affected units
- 2,420
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 0001
- and Lot# 0005
- within expiry
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Dabur India Limited under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Dabur India Limited
See all →- ModerateMed Pride hydrocortisone cream 1oz tubes recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateLucky Super Soft triple antibiotic ointment recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateLucky Super Soft athlete's foot cream recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateLil Drug Store triple antibiotic ointment recalled over manufacturing deviations
FDA (Drugs) · 2026-06-24
- ModerateCura Hongos clotrimazole cream recalled over manufacturing practice deviations
FDA (Drugs) · 2026-06-24
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateRapidol Triple Antibiotic Ointment Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- HighTriple Antibiotic Ointment Recalled Due to Improper Storage
FDA (Drugs) · 2022-08-17
- ModerateFDA recalls Akorn ophthalmic ointment for manufacturing process deviations
FDA (Drugs) · 2023-01-25
- LowSheffield Triple Antibiotic Ointment Recalled for Stability Failures
FDA (Drugs) · 2013-06-26
- HighFDA Recalls Akorn AK-POLY-BAC Eye Ointment for CGMP Violations
FDA (Drugs) · 2023-01-25
- SevereGlaxoSmithKline Recalls Bactroban Ointment Due to Penicillin Cross-Contamination
FDA (Drugs) · 2016-07-27